Ericksen Spencer S, Cummings David F, Weinstein Harel, Schetz John A
Department of Physiology and Biophysics, Weill Medical College of Cornell University, New York, New York, USA.
J Pharmacol Exp Ther. 2009 Jan;328(1):40-54. doi: 10.1124/jpet.108.141531. Epub 2008 Oct 10.
We have uncovered a significant allosteric response of the D(2) dopamine receptor to physiologically relevant concentrations of sodium (140 mM), characterized by a sodium-enhanced binding affinity for a D(4)-selective class of agonists and antagonists. This enhancement is significantly more pronounced in a D(2)-V2.61(91)F mutant and cannot be mimicked by an equivalent concentration of the sodium replacement cation N-methyl-D-glucamine. This phenomenon was explored computationally at the molecular level by analyzing the effect of sodium binding on the dynamic properties of D(2) receptor model constructs. Normal mode analysis identified one mode (M(19)), which is involved in the open/closed motions of the binding cleft as being particularly sensitive to the sodium effect. To examine the consequences for D(2) receptor ligand recognition, one of the ligands, L-745,870 [3-{[4-(4-chlorophenyl) piperazin-1-yl]-methyl}-1H-pyrrolo[2,3-b]pyridine or CPPMA, chlorophenylpiperazinyl methylazaindole], was docked into conformers along the M(19) trajectory. Structurally and pharmacologically well established ligand-receptor interactions, including the ionic interaction with D3.32(114) and interactions between the ligand aryl moieties and V2.61(91)F, were achieved only in "open" phase conformers. The docking of (-)-raclopride [3,5-dichloro-N-(1-ethylpyrrolidin-2-ylmethyl)-2-hydroxy-6-methoxybenzamide] suggests that the same binding cleft changes in response to sodium-binding perturbation account as well for the enhancements in binding affinity for substituted benzamides in the wild-type D(2) receptor. Our findings demonstrate how key interactions can be modulated by occupancy at an allosteric site and are consistent with a mechanism in which sodium binding enhances the affinity of selected ligands through dynamic changes that increase accessibility of substituted benzamides and 1,4-DAP ligands to the orthosteric site and accessibility of 1,4-DAPs to V2.61(91)F.
我们发现D2多巴胺受体对生理相关浓度的钠(140 mM)有显著的变构反应,其特征是对一类D4选择性激动剂和拮抗剂的钠增强结合亲和力。这种增强在D2-V2.61(91)F突变体中更为明显,且同等浓度的钠替代阳离子N-甲基-D-葡糖胺无法模拟这种现象。通过分析钠结合对D2受体模型构建体动态特性的影响,在分子水平上对这一现象进行了计算探索。正常模式分析确定了一种模式(M(19)),它参与结合裂隙的开放/关闭运动,对钠效应特别敏感。为了研究对D2受体配体识别的影响,将其中一种配体L-745,870 [3-{[4-(4-氯苯基)哌嗪-1-基]-甲基}-1H-吡咯并[2,3-b]吡啶或CPPMA,氯苯基哌嗪基甲基氮杂吲哚] 沿M(19)轨迹对接至构象异构体。只有在 “开放” 相构象异构体中才能实现结构和药理学上已确立的配体-受体相互作用,包括与D3.32(ll4)的离子相互作用以及配体芳基部分与V2.61(91)F之间的相互作用。(-)-雷氯必利 [3,5-二氯-N-(1-乙基吡咯烷-2-基甲基)-2-羟基-6-甲氧基苯甲酰胺] 的对接表明,野生型D2受体中对钠结合扰动的相同结合裂隙变化也解释了对取代苯甲酰胺结合亲和力的增强。我们的研究结果证明了关键相互作用如何通过变构位点的占据来调节,并且与一种机制一致,即钠结合通过动态变化增强选定配体的亲和力,这种动态变化增加了取代苯甲酰胺和1,4-DAP配体对正构位点的可及性以及1,4-DAP对V2.61(91)F的可及性。